Roche Diagnostics supplies products and services spanning the entire in-vitro diagnostic testing market — from products for scientific research, to clinical laboratory systems and devices for patient self-monitoring

Our position as one of the world’s leading diagnostics companies is built on intensive research and a broad array of product offerings. Diagnostics are playing an increasingly important role in healthcare — for example, in the early detection of disease susceptibilities and risk factors, in establishing whether patients will respond to a particular medicine and in monitoring patients’ responses to treatment.

Medicine is changing rapidly as new discoveries and technologies provide ever deeper insights into the molecular basis of disease.  Modern diagnostic tools are bringing us closer to personalised medicine by making it possible to identify differences in people’s genetic make-ups and determine how these differences affect responses to treatment.

The more we know about the causes of disease, the more accurately we can diagnose them. As the world’s leading supplier of diagnostics, Roche Diagnostics aims to give physicians, patients and healthcare payers optimal access to reliable information and thus facilitate rapid, appropriate clinical decision-making.

Genomics will contribute to a fuller, more precise understanding of the factors that cause disease and thus help in developing more targeted diagnostics and medicines. New applications will emerge for detecting predispositions for disease and enabling therapies to be better tailored to individual patients. While these new options, and in particular the data derived from them, promise to benefit patients, Roche also recognises their potential for abuse — a risk that exists with all medical data. To prevent abuses, while exploiting their uses, Roche has established stringent research and development guidelines of its own (over and above the safeguards required by law) and assembled an independent ethics panel to provide guidance and advice.

Our other major goal is to develop ways of translating raw clinical data into clinically useful information. Scientific advances and new diagnostic tests are generating an ever-growing flood of data, creating a need for systems that can integrate, process and analyse data from different sources. By making actionable information available to physicians, we can contribute to sounder therapeutic decision-making.